SAM #75D30126R73461

CDC Sole Source Contract for Chronic Kidney Disease Epidemiology Services in Military Health System

This notice announces the CDC's intent to award a sole source contract for epidemiological support services related to Chronic Kidney Disease (CKD) in the Military Health System. - Agency: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services - Sole Source Vendor: Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) - Scope of Work: - Access and analysis of Military Health System (MHS) data - Establishment and maintenance of an analytical database - Epidemiologic analyses of CKD and end-stage kidney disease (ESKD) - Risk factor assessment and disease pattern evaluation for active-duty and non-active-duty populations - Characterization of pediatric CKD and investigation of rare causes - Rationale: HJF is the only known vendor with the necessary access and capabilities to perform these services without disruption - No specific products or part numbers are listed; procurement is for specialized epidemiological services - Period of Performance: One-year base period with three one-year option periods (total up to four years) - Place of Performance: Bethesda, MD; Contracting Office: Atlanta, GA - Commercial Opportunity: Sole source contract for specialized CKD epidemiology services in the military health sector

Description

The Centers for Disease Control and Prevention (CDC) intends to award a sole source Firm-Fixed-Price contract to the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), 6720-A Rockledge Drive, Bethesda, MD 20817, for Chronic Kidney Disease Epidemiology in the Military Health System. The proposed contract will provide continued support for CDC’s Chronic Kidney Disease (CKD) surveillance and epidemiology activities through access to and analysis of Military Health System (MHS) data. The contractor will support establishment and maintenance of an analytical database used to assess the epidemiology of CKD diagnosis, treatment, complications, and outcomes within the MHS. The effort includes epidemiologic analyses of CKD and end-stage kidney disease (ESKD), assessment of risk factors, evaluation of disease patterns among active-duty and non-active-duty populations, characterization of pediatric CKD, and investigation of rare causes of CKD. This contract action is being conducted pursuant to FAR 6.302-1, Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements.

HJF is the only known source with the requisite access, resources, and capabilities necessary to support this requirement without disruption. Award to another source would result in substantial duplication of cost and unacceptable delays to the Government.

The anticipated period of performance is June 14, 2026 through June 13, 2030, consisting of a one-year base period and three one-year option periods.

This notice of intent is not a request for competitive proposals; however, all capability statements, proposals, or quotations received within fifteen (15) calendar days after publication of this notice shall be considered by the Government. A determination by the Government not to compete this proposed action based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for determining whether to conduct a competitive procurement. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. Responses shall be submitted electronically to the assigned CDC Contract Specialist identified in the SAM.gov notice by the date and time specified in the posting.  

View original listing